I'll make it a quick answer. What we're seeking is to have the data provisions that are in the switch legislation for the European Union included in the trade agreement so that we can parlay those into a Canadian benefit.
The reason for this is that Health Canada has said we will not put anything into our regulatory system unless directed to do so by an agreement. So far, the only existing agreement that impacts any kind of data exclusivity is TRIPS, and that's only for new chemical entities. It's the one that allows you to extend the use of something still under patent.